Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pat-CR 37.5 Tablet

Prescription Icon
Prescription Required

Marketer

V.M.S Pharma

Salt Composition

Paroxetine (37.5mg)

Overview Pat-CR 37.5 Tablet

Sertraline 37.5 mg extended-release tablets are an SSRI antidepressant frequently used to manage depression and related anxiety disorders such as obsessive-compulsive disorder and panic attacks. This medication assists many patients in recovering from depressive symptoms by elevating mood and alleviating anxiety and tension. It can be administered with or without food. Dosage and frequency are determined individually by your physician to optimize symptom control, often starting with a lower dose gradually increased as needed. Never alter your dosage or discontinue use without consulting your doctor; abrupt cessation can worsen your condition or trigger unpleasant withdrawal effects (including anxiety, restlessness, rapid heartbeat, dizziness, sleep problems, etc.). For optimal results, take this medication consistently at the same time daily; morning administration may be preferred if sleep disturbances occur. Significant improvement may take several weeks. Report lack of progress after four weeks of treatment. Common side effects include nausea, tiredness, dry mouth, appetite changes, increased perspiration, dizziness, nervousness, tremors, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately notify your doctor of any sudden mood worsening or suicidal thoughts. Before commencing treatment, inform your physician if you have epilepsy, diabetes, liver or kidney disease, cardiac conditions, or glaucoma, as these may influence treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Interactions with other medications, particularly other antidepressants and MAO inhibitors, are possible; always disclose all medications you are taking to ensure safety.

Primary Ingredients of Pat-CR 37.5 Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Pat-CR 37.5 Tablet

Managing depressive disorders | Addressing panic attacks and panic disorder | Anxiety disorder management

Major Benefits of Pat-CR 37.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Pat-CR 37.5 Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Pat-CR 37.5 Tablet:

  • Nausea
  • Fatigue
  • Dryness in mouth
  • Loss of appetite
  • Increased sweating
  • Dizziness
  • Nervousness
  • Tremors
  • Low sexual desire
  • Insomnia (difficulty in sleeping)
  • Confusion
  • Constipation
  • Erectile dysfunction
  • Delayed ejaculation
  • Decreased libido

How to use Pat-CR 37.5 Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption of Pat-CR 37.5 Tablet may coincide with meals or be taken independently, however, consistent timing is recommended.

How Pat-CR 37.5 Tablet works:

Pat-CR 37.5mg tablets contain a selective serotonin reuptake inhibitor (SSRI) that counteracts depression. The medication elevates serotonin, a neurotransmitter crucial for mood regulation, thus alleviating depressive symptoms, both emotional and physical, and also offering relief from panic disorder, anxiety, and obsessive-compulsive symptoms.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Pat-CR 37.5 Tablet is dangerous.

PregnancyPregnancyUNSAFE

Use of Pat-CR 37.5 Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal and human studies indicates substantial risks to the fetus.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Pat-CR 37.5 Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Pat-CR 37.5 Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when using Pat-CR 37.5 Tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise prudence when using Pat-CR 37.5 mg tablets. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Pat-CR 37.5 Tablet :

Should you forget a Pat-CR 37.5 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Pat-CR 37.5 Tablet

LabelValue
Chemical Type Piperidine Phenyl Derivative
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Behavioral Class Selective serotonin reuptake inhibitors (SSRIs)

FAQs on Pat-CR 37.5 Tablet

Noticeable symptom improvement may begin within one to two weeks of starting treatment. However, if you don't see improvement, continue the medication and consult your doctor. Complete benefits may take four to six weeks to become apparent.
Don't abruptly stop taking Pat-CR 37.5 Tablet without your doctor's advice. Initially, symptoms may worsen, but improvement usually appears within 1-2 weeks. If symptoms remain worse after 1-2 weeks, consult your doctor.
Using Pat-CR 37.5 Tablets may impact sexual function in both men and women, potentially reducing libido and causing difficulties with orgasm. Men may also experience erectile and ejaculatory dysfunction.
Pat-CR 37.5 Tablets are not suitable for children under 18. This is because younger patients face a higher risk of side effects including suicidal thoughts, aggression, oppositional behavior, and anger. If your child has been prescribed this medication and you have concerns, please talk to your doctor.
Don't take Pat-CR 37.5 Tablet if you're using tamoxifen. While Pat-CR 37.5 Tablet treats tamoxifen-induced hot flashes, it can diminish tamoxifen's effectiveness and increase the risk of breast cancer recurrence.
Diabetics should use Pat-CR 37.5 Tablet cautiously, as it can affect blood sugar levels, potentially requiring insulin or antidiabetic medication adjustments. Consult your doctor and monitor your blood sugar regularly.
Pat-CR 37.5 Tablet
216
MRP 250
13% off